This site is intended for Healthcare Professionals only.

AstraZeneca drug cocktail succeeds in late-stage study to treat Covid-19

Date:

Share post:

British pharmaceuticals giant AstraZeneca on Monday revealed more positive results from a trial of a treatment for Covid-19 symptoms.

The drug, made from a combination of two antibodies, achieved a “statistically significant reduction in severe Covid-19 or death” in non-hospitalised patients with mild-to-moderate symptoms, AstraZeneca said in a statement.

The group’s treatment, known as AZD7442, has been undergoing phase 3 or final clinical trials to assess its safety and efficacy.

“With continued cases of serious Covid-19 infections across the globe, there is a significant need for new therapies like AZD7442 that can be used to protect vulnerable populations… and can also help prevent progression to severe disease,” said principal trial investigator Hugh Montgomery.

“These positive results show that a convenient intramuscular dose of AZD7442 could play an important role in helping combat this devastating pandemic.”

The trial involved 903 participants and 90 percent of them were people at high risk of progression to severe Covid-19.

AstraZeneca’s separate Covid vaccine, developed with the University of Oxford, helped enable Britain’s speedy Covid vaccination drive.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

‘Big reforms needed to make NHS fit for the future,’ says former health secretary

Alan Milburn, known for reducing NHS waiting lists and improving patient satisfaction, will offer advice on turning the...

NHS England to relaunch Pharmacy First campaign on Monday

CPE calls for a longer-term Pharmacy First campaign to allow community pharmacies maximise their allocated funding  As NHS England...

Ban on sale and supply of puberty blockers further extended

The health secretary has expressed the intention to make the ban on puberty blockers permanent The UK government...

Why we need awareness weeks like National Self-Care Week

Trevor Gore, treasurer and trustee of the Self-Care Forum, explains how pharmacists can help reduce preventable illnesses by...